Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:

The biological assay (OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) and the criteria given in Annex I of Regulation (EC) 1272/2008), shows that the test item Prednisolone, as described in this report is expected to have no sensitising properties and therefore should not be regarded as a dermal sensitiser. (BSL Bioservice 104857)

The QSAR study carried out with QSAR Toolbox v.2.0 (2010), based on the general model for Skin sensitisation (Danish EPA DB), showed that prednisolone is skin sensitising. Due to the reliability of the source of this software, OECD, it was considered reliable for the first evaluation of this assessment.


Migrated from Short description of key information:
Prednisolone is not a skin sensitising.

Justification for classification or non-classification

In accordance to Directive 67/548/EEC, classification is not necessary for sensitisation based on the available data.